Header image

Clinical Management of COVID-19 in the 4th Year of the Pandemic

Thursday, July 27, 2023
1:30 PM - 3:00 PM
Ballroom 2


1. Learn how to select optimal antivirals for elderly individuals in the community 
2. Understand the latest advances in treatment for profoundly immunocompromised individuals with COVID-19 
3. Review recent data and clinical considerations for anticoagulation in patients hospitalised with COVID-19 
4. Explore progress in immunomodulator therapy for COVID-19 and apply the lessons to other respiratory tract infections. 


Agenda Item Image
Associate Professor Suman Majumdar
Deputy Program Director
Burnet Institute

Real-World Effectiveness of Oral Antivirals for COVID-19: The Victorian Experience

1:30 PM - 1:50 PM

presentation recording


Associate Professor Suman Majumdar is an infectious diseases physician, public health practitioner and researcher. He has been a Deputy Chief Health Officer for the COVID-19 response at the Victorian Department of Health since 2021. Suman is the Deputy Program Director for Health Security and Pandemic Preparedness and a principal research fellow at the Burnet Institute and has appointments at the Alfred Hospital and Monash University.
Agenda Item Image
Prof Zoe K McQuilten
Monash University

Anticoagulation in hospitalised patients with COVID-19 infection 

1:50 PM - 2:10 PM

presentation recording


Professor Zoe McQuilten is a haematologist at Monash Health and a NHMRC Emerging Leadership Fellow at Monash University. She is Deputy Director of the Transfusion Research Unit, School of Public Health and Preventive Medicine at Monash University. Her research is focused on interventions to improve supportive care in blood cancers and transfusion in areas of major blood use, including blood diseases, critical care and trauma. She is lead investigator on a number of national and international clinical trials and oversees a large clinical registry program.
Agenda Item Image
Associate Professor Andrea Henden
Royal Brisbane and Women's Hospital

Treatment for profoundly immunocompromised individuals with COVID-19

2:10 PM - 2:30 PM

presentation recording


A/Prof Andrea Henden (BSc MBBS (Hons) FRACP FRCPA PhD) is a clinical Haematologist and Bone Marrow Transplant physician with an interest in cellular therapies at the Royal Brisbane and Women's Hospital in Brisbane, Australia and a holder of a Metro North Clinician Research Fellowship. She is also a research officer and immunologist in the Translational Cancer Immunotherapy Laboratory at QIMR Berghofer Medical Research Institute.
Agenda Item Image
Dr Tom Hills
Infectious Diseases Physician & Clinical Immunologist
Middlemore Hospital & Mrinz

Immunomodulator therapy for COVID-19 and beyond

2:30 PM - 2:50 PM

presentation recording


Tom Hills is an Infectious Diseases Physician and Clinical Immunologist from Auckland, New Zealand, with a research interest in infections in the critically ill. He is involved in the REMAP-CAP trial and leads a new REMAP-CAP domain studying tocilizumab and baricitinib in patients with severe influenza.
Dr Adi Idris
Group leader
Queensland University of Technology

Prophylactic intranasal administration of lipid nanoparticle formulated siRNAs reduce SARS-CoV-2 and RSV lung infection

2:50 PM - 3:02 PM

Abstract PDF

presentation recording


Dr Adi Idris is a virologist with a research focus on developing novel therapeutic strategies to treat diseases using gene editing and silencing technologies. He developed the world’s first direct acting antiviral therapy for COVID-19. He is a group leader at the Queensland University of Technology.

Chair Person

Krispin Hajkowicz
Senior Staff Specialist

Susan Morpeth
Clinical Microbiologist And Infectious Diseases Physician
Middlemore Hospital, Te Whatu Ora